Skip to Main Content
Contact Us
Clinical Research Organization

Early Phase Oncology Clinical Research Expertise 

Catalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.

Choose Catalyst Oncology for Early Phase Research

Catalyst Oncology supports first-in-human (FIH), Phase I, and Phase II studies. Our experts understand dose escalations and amendments necessary to reach required milestones. Our early phase oncology site network connects us to patients and professionals to succeed in early phase trials.

Learn More About Early Phase Expertise
Why choose Catalyst Oncology for early phase clinical studies?

At Catalyst Oncology, we’re pioneering oncology advancements from the start. Here’s why you should choose us for your early phase research

Contact Us
Catalyst experience

Catalyst Oncology has more than 18 years delivering oncology staff and studies. We have served the biotech space since 2005 and supported over 150 oncology studies. We draw on our robust and active pipeline for best practices and lessons learned.

Scientific excellence

Our multidisciplinary teams of experts translate scientific discoveries into potential therapies, driving advancements in oncology. We collaborate closely with sponsors, sites, investigators, and researchers to help develop innovative cancer therapies.

Flexible approach

We understand that change is inevitable in oncology clinical development. We pivot as your development plans evolve, such as when protocols amend or when Breakthrough Therapy designations move a product from Phase I to registration.

Operational excellence

Catalyst Oncology Consulting provides clinical development planning, protocol writing, regulatory consulting, and our oncology drug development team share study design, timeline modeling, and ballpark costing.

My Catalyst team is an extension of my internal team. The team is very transparent and communicative. They are aware of the trial timelines and each department helps to keep the study on track.

The project team anticipates and provides solution-based responses to the current challenges on a given study, which is the essential need for any Sponsor as each protocol evolves and changes based on the clinical data collected.

Discover the Catalyst Oncology Difference

Explore our comprehensive early phase research capabilities and learn how Catalyst Oncology propels your cancer research.